Related by context. All words. (Click for frequent words.) 80 leukemia AML 75 leukemia CLL 74 chronic myeloid leukemia CML 74 pediatric acute lymphoblastic 73 Myelodysplastic Syndrome MDS 73 leukemia CML 72 Chronic Myeloid Leukemia 72 childhood acute lymphoblastic 72 metastatic malignant 72 cell acute lymphoblastic 72 Leukemias 72 acute leukemias 72 chronic eosinophilic leukemia 72 acute lymphoblastic 71 cell lymphoma CTCL 71 acute myelogenous leukemia AML 71 non metastatic osteosarcoma 71 precursor acute lymphoblastic 71 chronic lymphocytic leukemia CLL 70 lymphoblastic leukemia 70 leukaemias 70 Glioblastoma Multiforme 70 hypereosinophilic syndrome 70 idiopathic thrombocytopenic purpura ITP 70 chronic myeloid 70 essential thrombocythemia 70 chronic granulomatous disease 69 relapsed acute lymphoblastic 69 Chronic lymphocytic leukemia CLL 69 Acute Myeloid Leukaemia AML 69 recurrent glioblastoma multiforme 69 Cutaneous T 69 Philadelphia Chromosome Positive 69 tumors GIST 69 Acute Myelogenous Leukemia AML 69 Gleevec resistant 69 imatinib Gleevec ® 69 metastatic kidney 69 MALT lymphoma 69 ADPKD 69 chronic myelogenous leukemia CML 69 myelodysplastic syndrome MDS 69 Chronic lymphocytic leukemia 69 lymphocytic leukemia 69 MCyR 69 gastrointestinal stromal tumors GIST 69 grade cervical intraepithelial 68 Acute Myelogenous Leukemia 68 myeloproliferative neoplasms 68 Chronic Myelogenous Leukemia CML 68 antibody MAb 68 Acute Myeloid Leukemia AML 68 imatinib Gleevec 68 Kit CD# positive 68 Waldenstrom macroglobulinemia 68 Hodgkin lymphoma HL 68 Acute Lymphocytic Leukemia 68 gastrointestinal stromal tumor GIST 68 hepatocellular carcinoma HCC 68 refractory chronic lymphocytic 68 myelodysplastic myeloproliferative diseases 68 hypophosphatasia 68 refractory cutaneous T 68 Hodgkin lymphoma NHL 68 acute lymphoblastic leukemia 68 MELAS 68 refractory acute myeloid 68 Ph + acute lymphoblastic 68 acute myeloid 68 dasatinib Sprycel 68 HBeAg negative 68 recurrent glioblastoma 68 Relapsed Refractory 68 Annamycin 68 Epratuzumab 68 cetuximab Erbitux R 67 familial amyloidotic polyneuropathy FAP 67 CMV infection 67 Acute Lymphoblastic Leukemia 67 SPRYCEL ® 67 Telintra 67 hepatorenal syndrome 67 GISTs 67 TTR amyloidosis 67 invasive candidiasis 67 SSc 67 metastatic malignant melanoma 67 Omacetaxine 67 acute GvHD 67 CYT# potent vascular disrupting 67 BARACLUDE ® 67 lupus nephritis 67 PTLD 67 juvenile myelomonocytic leukemia 67 hematologic disorders 67 Chronic Lymphocytic Leukemia 67 cytogenetic responses 67 eosinophilic asthma 67 medulloblastoma 67 gastrointestinal stromal tumors 67 smoldering myeloma 67 Malignant Melanoma 67 refractory gout 67 Hepatocellular Carcinoma HCC 67 refractory anaplastic astrocytoma 67 Severe Sepsis 67 idiopathic thrombocytopenic purpura 67 ependymoma 66 refractory chronic myeloid 66 metastatic gastric 66 lymphoid malignancies 66 cell lymphoma ALCL 66 metastatic renal cell carcinoma 66 systemic anaplastic large 66 Acute Leukemia 66 Idiopathic Pulmonary Fibrosis 66 ATTR 66 Acute myeloid leukemia 66 metastatic renal cell 66 ara C 66 relapsed ALL 66 haematological malignancies 66 medulloblastomas 66 relapsed MM 66 juvenile idiopathic arthritis JIA 66 non splenectomized 66 cutaneous T 66 relapsed leukemia 66 severe oral mucositis 66 basal cell nevus syndrome 66 SJIA 66 herpes zoster shingles 66 Acute lymphoblastic leukemia 66 systemic lupus erythematosus 66 refractory AML 66 lupus erythematosus 66 T Cell Lymphoma 66 Non Alcoholic Steatohepatitis 66 gastrointestinal stromal tumor 66 ankylosing spondylitis AS 66 dasatinib Sprycel ® 66 Follicular Lymphoma 66 Chronic Lymphocytic Leukemia CLL 66 dasatinib 66 blastic phase 66 Myelodysplastic Syndrome 66 Brentuximab Vedotin SGN 66 TTR gene 66 basal cell carcinoma BCC 66 autoantibody positive 66 mRCC 66 relapsed refractory 66 HBeAg 66 castration resistant prostate cancer 66 MYCN amplification 65 Hydroxyurea 65 acute leukemia AML 65 psoriatic arthritis PsA 65 Myelofibrosis 65 HBeAg positive patients 65 atypical hemolytic uremic syndrome 65 subependymal giant cell 65 Gleevec imatinib mesylate 65 HeFH 65 epithelial tumors 65 HBeAg positive 65 Severe Primary IGFD 65 chronic immune thrombocytopenic 65 T1DM 65 JAK2 V#F 65 Dasatinib 65 systemic lupus erythematosus SLE 65 hepatoblastoma 65 Cell Lymphoma 65 idiopathic pulmonary fibrosis IPF 65 glioblastoma multiforme GBM 65 myeloproliferative disorders 65 Bronchiectasis 65 combination antiretroviral therapy 65 colorectal carcinoma 65 multiple myeloma MM 65 myeloproliferative diseases 65 refractory CTCL 65 imatinib therapy 65 pheochromocytoma 65 Acute Lymphoblastic Leukaemia 65 Fludarabine 65 relapsed multiple myeloma 65 Chronic Myelogenous Leukemia 65 nasopharyngeal carcinoma 65 Cholangiocarcinoma 65 myelogenous leukemia 65 candidemia 65 untreated chronic lymphocytic 65 alfa 2a 65 relapsing remitting multiple sclerosis 65 astrocytomas 65 thalidomide Thalomid 65 Myelodysplastic syndromes MDS 65 receptor tyrosine kinase inhibitor 65 diabetes mellitus DM 65 ATTR PN 65 heavily pretreated 65 Hurler syndrome 65 K ras mutations 65 HER2 positive metastatic breast 65 myelofibrosis polycythemia vera 65 Sprycel dasatinib 65 systemic fungal infections 65 refractory indolent non 65 complete cytogenetic response 65 relapsed refractory multiple myeloma 65 type 1diabetes 65 relapsed Acute Myeloid 65 erlotinib Tarceva ® 65 enterocolitis 65 Bezielle 65 myelofibrosis 65 pancreatic neuroendocrine tumors 65 Acute Myeloid Leukemia 65 Sezary syndrome 65 FluCAM arm 65 evaluating tivozanib 65 CLL SLL 65 hyperphenylalaninemia HPA due 64 leukemia APL 64 Ribavirin causes 64 relapsed acute myelogenous 64 relapsing multiple sclerosis 64 nucleotide analog 64 Acute Myeloid Leukaemia 64 pancytopenia 64 pancreatic adenocarcinoma 64 cancer mCRC 64 prostate cancer CRPC 64 Alzheimer Disease AD 64 Glioblastoma multiforme GBM 64 choriocarcinoma 64 complement inhibitor eculizumab 64 leukoencephalopathy 64 FOLOTYN ® 64 EGFR inhibitors 64 Multiple Myeloma MM 64 myelodysplastic syndromes MDS 64 mycosis fungoides 64 SNT-MC#/idebenone 64 Velcade bortezomib 64 stage IIIB 64 transplantation HSCT 64 metastatic castration resistant 64 immune thrombocytopenic purpura ITP 64 Fludara ® 64 recurrent NSCLC 64 formerly LymphoStat B 64 CTAP# Capsules 64 T2DM 64 polycythemia vera essential thrombocythemia 64 FSGS 64 ribavirin RBV 64 chronic HBV 64 tuberous sclerosis complex 64 JAK mutations 64 lymphoblastic lymphoma 64 Heterozygous Familial Hypercholesterolemia 64 invasive aspergillosis 64 VUR 64 carcinoid 64 JMML 64 Idiopathic Thrombocytopenic Purpura ITP 64 severe neutropenia 64 metastatic bladder 64 autologous transplants 64 Glioblastoma Multiforme GBM 64 aggressive systemic mastocytosis 64 CMV disease 64 Lupus Nephritis 64 hepatitis C HCV 64 essential thrombocythemia ET 64 mutated KRAS 64 Evoltra ® 64 paraganglioma 64 myeloid leukemia 64 ErbB2 positive 64 imatinib resistant 64 sJIA 64 Gleevec imatinib 64 glioblastoma tumors 64 T#I mutant 64 Nephrotic Syndrome 64 Anaplastic 64 lymphoma CTCL 64 bladder carcinoma 64 Duchenne Muscular Dystrophy DMD 64 acute myeloid leukemia AML 64 zanolimumab 64 systemic ALCL 64 resistant hormone refractory 64 thymoma 64 hepatocellular cancer 64 cetuximab Erbitux 64 acute promyelocytic leukemia 64 Toxicities 64 bacteraemia 64 Glioblastoma 64 HSCT 64 Genentech Rituxan 64 canakinumab 64 neuroblastomas 64 GvHD 64 post transplant lymphoproliferative 64 PEGylated interferon beta 1a 64 pan HDAC inhibitor 64 gastric carcinoma 64 Nilotinib 63 neutropenia dehydration dyspnea 63 Non Hodgkin 63 Thrombocytopenia 63 nonalcoholic steatohepatitis NASH 63 familial ALS 63 purpura ITP 63 de novo AML 63 allogeneic bone marrow 63 HIV HCV coinfected 63 Complicated Skin 63 EXJADE 63 onset diabetes mellitus 63 MGUS 63 variceal bleeding 63 CCyR 63 Flu Cy 63 refractory acute lymphoblastic 63 PROSTVAC VF 63 Vidaza azacitidine 63 ovarian carcinoma 63 astrocytoma 63 idiopathic PAH 63 cetuximab Erbitux ® 63 hemolytic anemia 63 transplantation HCT 63 AVONEX ® 63 diabetic gastroparesis 63 myeloid 63 deletion 5q 63 medullary thyroid cancer 63 Renal Cell Carcinoma RCC 63 renal cell carcinomas 63 Burkitt lymphoma 63 HCV infection 63 vWD 63 basiliximab 63 cirrhosis liver failure 63 metastatic lung cancer 63 neuroendocrine cancers 63 cabazitaxel 63 nephrotic syndrome 63 Quinamed 63 carcinoid tumors 63 TACI Ig 63 progressive neurodegenerative disorder 63 Natalizumab 63 gefitinib Iressa 63 metastatic GIST 63 fallopian tube carcinoma 63 pancreatic NET 63 minimally symptomatic metastatic castrate 63 B CLL 63 allogeneic HSCT 63 idiopathic myelofibrosis 63 Zarnestra 63 leiomyosarcoma 63 indolent follicular non 63 sunitinib Sutent ® 63 nonsmall cell lung cancer 63 PKC# 63 prostate adenocarcinoma 63 lumiliximab 63 Trastuzumab 63 Decitabine 63 cytomegalovirus infection 63 HER2 overexpression 63 prostate cancer mCRPC 63 cutaneous T cell 63 homozygous familial hypercholesterolemia 63 lymphoproliferative disorders 63 juvenile idiopathic arthritis 63 opioid induced constipation OIC 63 cytopenias 63 AEG# 63 Rheumatoid Arthritis RA 63 panobinostat 63 nutlin 3a 63 ® lenalidomide 63 Epstein Barr virus EBV 63 lenalidomide Revlimid R 63 Lymphocytic 63 imatinib resistance 63 B Cell Lymphoma 63 BRAF V#E 63 castrate resistant 63 pemphigus vulgaris 63 Acute myelogenous leukemia 63 INCB# [001] 63 docetaxel Taxotere ® 63 colorectal cancer CRC 63 Myelodysplasia 63 Leber Hereditary Optic Neuropathy 63 galiximab 63 lymphoid blast 63 Glioma 63 efalizumab 63 Follicular lymphoma 63 relapsed AML 63 PEGylated Fab fragment 63 anterior uveitis 63 biliary tract cancer 63 Alemtuzumab 63 torsade de pointes 63 decitabine 63 acute lymphoid leukemia 63 plus dexamethasone 63 Rituxan rituximab 63 Nexavar sorafenib 63 gastric adenocarcinoma 63 alpha folate receptor 63 docetaxel chemotherapy 63 neurological manifestations 63 non hodgkin lymphoma 63 advanced hepatocellular carcinoma 63 PNP inhibitor 63 cell malignancies 63 erythematosus 63 forodesine 63 Mantle Cell Lymphoma 63 nonmetastatic 63 situ CIS 63 HBeAg negative patients 63 lymphocytosis 63 adriamycin 63 prostate cancer CaP 63 AVASTIN 63 BRAF V#E mutation 63 recurrent VTE 63 Uricase PEG 63 PRTX 63 Cloretazine 63 LHRH receptor positive 63 Diffuse Large B 63 Chronic myeloid leukemia 63 oropharyngeal candidiasis OPC 63 CD3 monoclonal antibody 63 seropositive patients 63 hepatic encephalopathy HE 63 Wilms tumor 63 haematologic malignancies 63 malignant lymphomas 63 Phase 2b Clinical Trial 62 cytogenetic response 62 PDGFRA 62 external genital lesions 62 synovial sarcoma 62 KRAS mutant tumors 62 alveolar rhabdomyosarcoma 62 hA# 62 Zolinza 62 DIPG 62 phase IIb trial 62 recurrent ovarian cancer 62 investigational monoclonal antibody 62 systemic juvenile idiopathic 62 recurrent glioblastoma multiforme GBM 62 leukemias 62 Graft Versus Host 62 depsipeptide 62 stage IIIB IV 62 velafermin 62 acute myelogenous 62 nucleoside analogue 62 prostate cancer HRPC 62 oblimersen 62 huN# DM1 62 peripheral sensory neuropathy 62 disease CDAD 62 castrate resistant prostate cancer 62 transthyretin TTR mediated amyloidosis 62 Adjuvant Treatment 62 Mitoxantrone 62 Advanced Renal Cell 62 Juvenile Idiopathic Arthritis 62 Voreloxin 62 Ph + 62 Ceflatonin 62 glioblastoma 62 invasive ductal 62 acute myeloid leukemia 62 Non Hodgkin Lymphoma 62 stage IIIb 62 pertuzumab 62 previously untreated follicular 62 Carcinoma 62 Revlimid lenalidomide 62 haematologic 62 micafungin 62 T#I [002] 62 nilotinib 62 HNSCC 62 recurrent genital herpes 62 alefacept 62 relapsed CLL 62 osteosarcomas 62 Osteosarcoma 62 Gliomas 62 Xyfid TM 62 Aflibercept 62 lymphoproliferative disorder 62 esophageal candidiasis 62 SUPPRELIN R LA 62 chronic GVHD 62 hematological malignancy 62 metastatic neuroendocrine tumors 62 adalimumab Humira 62 T#I mutation 62 precancerous cervical lesions 62 Newly Diagnosed Multiple Myeloma 62 haematological cancers 62 Romiplostim 62 INCB# [003] 62 Myelodysplastic Syndromes 62 GH deficiency 62 cutaneous melanoma 62 Janus kinase 62 Elotuzumab 62 Degarelix 62 PAOD 62 EGFR TKI 62 haloperidol Haldol 62 sitaxsentan 62 chronic hepatitis cirrhosis 62 FOLFOX6 62 neuroendocrine tumors 62 SNT MC# 62 bronchopulmonary dysplasia 62 Wiskott Aldrich syndrome 62 alpha1 antitrypsin AAT deficiency 62 squamous cell lung cancer 62 HCV infections 62 follicular lymphoma FL 62 refractory CLL 62 gastrointestinal stromal tumors GISTs 62 varicella zoster virus VZV 62 Carcinoid tumors 62 NS#/#A protease 62 papillary renal cell carcinoma 62 immunocompetent 62 Chronic Myeloid Leukemia CML 62 malignant ascites 62 malignant pleural mesothelioma 62 Epstein Barr Virus EBV 62 NMIBC 62 HuMax CD4 62 cervical intraepithelial neoplasia 62 lintuzumab SGN 62 generalized seizures 62 ACZ# 62 hepatocellular carcinoma 62 Metastatic breast cancer 62 Idiopathic pulmonary fibrosis 62 cervical carcinoma 62 ANCA associated 62 AZT zidovudine Retrovir 62 recurrent glioma 62 idarubicin 62 relapsing remitting MS RRMS 62 BENLYSTA TM 62 MabThera Rituxan 62 mediated apoptosis 62 virus HCV infection 62 decompensated liver disease 62 pomalidomide 62 imatinib mesylate Gleevec 62 Tasimelteon 62 unresectable stage 62 erlotinib Tarceva 62 SGPT 62 Xanafide 62 leukemia 62 lymphoid tumors 62 nephritis 62 cholangiocarcinoma 62 metastatic colorectal 62 autoimmune hemolytic anemia 62 Leber Congenital Amaurosis LCA 62 posterior uveitis 62 SCCHN 62 neuroblastoma tumors 62 tuberous sclerosis TS 62 Cytomegalovirus 62 Vandetanib 62 superficial bladder cancer 62 refractory myeloma 62 elotuzumab 62 Doxil ® 62 IL# PE#QQR 62 CR nPR 62 REVLIMID ® 62 DLBCL 62 chronic hepatitis 62 cell lymphomas 62 oxaliplatin Eloxatin 62 Adenomas 62 e antigen HBeAg 62 myelofibrosis MF 62 Hormone Refractory Prostate Cancer 62 atypical Hemolytic Uremic Syndrome 62 tumor lysis syndrome 62 Paraplatin ® 62 Imatinib 62 post herpetic neuralgia PHN 62 macroglobulinemia 62 Amgen Neulasta R 62 Vicriviroc 62 malignant lymphoma 62 vidofludimus 62 soluble tumor necrosis 62 Folfox 62 IMA# 62 receiving VICTRELIS 62 alcoholic hepatitis 62 Ph + ALL 62 Amrubicin 62 node metastases 62 PEGylated anti 62 PCNSL 62 biochemical relapse 62 indolent NHL 62 dual endothelin receptor antagonist 62 seminoma 62 mepolizumab 62 steroid refractory ulcerative 62 alemtuzumab treated 62 nucleoside analog 62 bevacizumab Avastin ® 62 receptor blocker 62 panitumumab Vectibix 62 differentiated thyroid 62 grade gliomas 62 Candida infection 62 GRASPA ® 62 liver transplantations 62 vandetanib 62 myelodysplastic syndromes 62 hepatic fibrosis 62 refractory Hodgkin 62 Idiopathic Pulmonary Fibrosis IPF 62 pediatric malignancies 62 Kinoid 62 systemic lupus erythematosus psoriasis 62 HBV infection 62 Squamous 62 Vidaza ® 62 cystic fibrosis CF 62 Bosutinib 62 HBeAg negative chronic hepatitis 62 activating mutations 62 TTF Therapy 62 YONDELIS 62 HbF 62 advanced adenoma 62 lymphopenia 62 Acute myeloid leukemia AML 62 Raptiva ® 62 Gleevec Glivec 62 WT1 62 complete cytogenetic 62 nilotinib Tasigna 62 medulloblastoma tumors 62 stage IIIb IV 62 trastuzumab Herceptin ® 62 TELINTRA 62 rituximab refractory 61 epithelial ovarian 61 chronic HCV infection 61 Etanercept 61 azacitidine 61 myeloproliferative disease 61 blood phenylalanine Phe 61 chlamydial infection 61 simplex virus 61 Phase #/#a trial 61 Medulloblastoma 61 BMPR2 61 LymphoStat B belimumab 61 monocytic 61 myeloproliferative disorder 61 partial onset seizures 61 Non Hodgkin lymphoma 61 AA amyloidosis 61 chronic HCV 61 Systemic Lupus Erythematosus 61 metastatic RCC 61 Herceptin trastuzumab 61 varicella zoster virus 61 relapsed ovarian cancer 61 advanced carcinoid 61 Crohn disease CD 61 antiretroviral naive 61 effector function 61 C1 INH deficiency 61 LHON 61 non Hodgkin lymphomas 61 Non Hodgkins lymphoma 61 Acute Leukaemia 61 RSV infection 61 acute lymphocytic leukemia 61 secondary hyperparathyroidism 61 targeting CD# 61 bendamustine 61 relapsing MS 61 Jevtana 61 respiratory viral infections 61 Azacitidine 61 thrombocytopenia neutropenia 61 Aplidin 61 anti leukemic 61 Leber congenital amaurosis LCA 61 clodronate 61 VFEND 61 Azedra 61 FLT3 61 relapsing remitting 61 leukemias lymphomas 61 lenalidomide dexamethasone 61 refractory multiple myeloma 61 GRN# 61 renal cell carcinoma 61 protease inhibitor PI 61 lobular carcinoma 61 TO AVOID PREGNANCY WHILE 61 HuMax EGFr 61 progressive PsA 61 Blinatumomab 61 Femara letrozole 61 Alocrest 61 chronic idiopathic 61 NPHP 61 Zorbtive TM 61 cervical dysplasia 61 intravascular hemolysis 61 lymphoma leukemia 61 hematologic toxicity 61 phase IIb clinical 61 graft dysfunction 61 Krabbe Disease 61 chlorambucil 61 lymphomas 61 GIST tumors 61 neoplasias 61 Atypical Hemolytic Uremic Syndrome 61 Torisel 61 Fludara 61 latent tuberculosis infection 61 syngeneic 61 infantile spasms 61 Niemann Pick disease 61 interleukin IL -# 61 spinal muscular atrophy SMA 61 Hodgkin Lymphoma 61 Copegus ribavirin 61 follicular Non Hodgkin 61 lung fibrosis 61 cytoreduction 61 myelodysplasia 61 beta thalassemia 61 refractory CML 61 Antitumor Activity 61 IV NSCLC 61 arthritis PsA 61 cilengitide 61 rituximab Rituxan 61 Anthracycline 61 castration resistant 61 CIMZIA TM 61 pegylated liposomal doxorubicin 61 hypoxia inducible factor 61 active ankylosing spondylitis 61 Personalized Immunotherapy 61 thrombocytopenic 61 Irinotecan 61 coinfected 61 chronic HBV infection 61 deep venous thromboses 61 cyclophosphamide FC 61 Pseudomonas aeruginosa infections 61 Enzastaurin 61 endometrial hyperplasia 61 small lymphocytic lymphoma 61 SHPT 61 breast carcinomas 61 inhaled liposomal ciprofloxacin 61 elevated ALT 61 virologic failure 61 rALLy 61 Hematologic 61 urothelial bladder cancer 61 Parathyroid Hormone 61 Spinal Muscular Atrophy SMA 61 phase IIb study 61 primary hypercholesterolemia 61 hormone refractory metastatic prostate 61 diffuse intrinsic pontine glioma 61 Plicera 61 AA Amyloidosis 61 pancreatic insufficiency 61 CDK inhibitor 61 AML MDS 61 Papillary 61 measurable tumor regressions 61 Safinamide 61 hepatocellular carcinomas 61 myeloproliferative 61 FluCAM 61 HDAC Inhibitor 61 Staphylococcus aureus infections 61 Romidepsin 61 Ph + CML 61 familial hypercholesterolemia FH 61 elacytarabine 61 grade glioma 61 Ilaris 61 embryonal rhabdomyosarcoma 61 AGILECT R 61 myoclonic seizures 61 Vaccine Recombinant 61 NNRTIs 61 renal carcinoma 61 MPS VI 61 cisplatin chemotherapy 61 Systemic Juvenile Idiopathic 61 luteinizing hormone releasing 61 Ozarelix 61 mapatumumab 61 imatinib mesylate 61 sorafenib Nexavar 61 CHOP chemotherapy 61 ELACYT 61 immunocompetent patients 61 dyskeratosis congenita 61 CIMZIA TM certolizumab pegol 61 delayed CINV 61 diabetic neuropathic pain 61 Relapsing Remitting Multiple Sclerosis 61 Escherichia coli Klebsiella pneumoniae 61 GOUT 61 endometrial carcinoma 61 Non Hodgkins Lymphoma 61 mitoxantrone plus 61 primary immunodeficiency PI 61 bone metastasis 61 cell carcinoma RCC 61 bexarotene 61 pancreatic carcinoma 61 Previously Treated 61 Temsirolimus 61 corticosteroid dexamethasone 61 Systemic lupus erythematosus 61 interferon beta 1a infertility 61 Phase Ib clinical 61 anaplastic astrocytomas 61 allograft rejection 61 bronchogenic carcinoma 61 lapatinib Tykerb 61 Stomatitis 61 visilizumab 61 MGd 61 diagnosed Ph + 61 juvenile myoclonic epilepsy 61 operable breast cancer 61 commercialize deforolimus 61 febrile neutropenia 61 lymphoma subtypes 61 rheumatoid arthritis RA psoriatic 61 oligodendrogliomas 61 Crohns disease 61 denileukin diftitox 61 Testicular cancer 61 NF1 61 registrational trial 61 abacavir Ziagen 61 chronic idiopathic thrombocytopenic purpura 61 R Saizen R 61 hypophosphatemia 61 de novo kidney transplant 61 ulcerative colitis UC 61 recurrent wheezing 61 diabetic kidney 61 chronic ITP 61 Kaposi sarcoma KS 61 squamous cell carcinoma SCC 61 NOMID 61 omacetaxine mepesuccinate 61 refractory NSCLC 61 Sapacitabine 61 diarrhea predominant irritable 61 bladder ovarian 61 histological subtype 61 achieved CCyR 61 Lennox Gastaut syndrome 61 Oral Fingolimod 61 Wilms tumors 61 ACTEMRA TM 61 multiple myeloma 61 Campath alemtuzumab 61 ocrelizumab 61 MYLOTARG 61 EFFEXOR XR 61 Host Disease GvHD 61 Pharmacokinetics PK 61 JAK1 61 Cimzia TM 61 Eltrombopag 61 cis retinoic acid 61 methicillin susceptible Staphylococcus aureus 61 Bosentan 61 pegfilgrastim 61 Kepivance 61 DFMO 61 carcinoid cancer 61 bone marrow reticulin deposition 61 axitinib 61 HCV infected 61 Golimumab 61 TNF Tumor Necrosis Factor 61 paclitaxel Taxol R 61 radezolid 61 Hashimoto thyroiditis 61 Angioedema 61 beta 1a 61 KRAS wild 61 liver scarring 61 lung metastasis 61 ATTR CM 61 cell chronic lymphocytic 61 AML acute myeloid 61 Troxatyl 61 cyclophosphamide methotrexate 61 Abrupt discontinuation 61 MULTAQ 61 BRAF V# mutation 61 relapsed refractory AML 61 Peginterferon alfa 2b 61 adult chronic ITP 61 ON #.Na 61 carcinoma mCRC 61 polycythemia vera PV 61 adjuvant tamoxifen 61 MyVax R 61 LY# [003] 61 Wilms Tumor 61 follicular lymphoma 61 TYGACIL 61 HER2 positive breast cancer 61 bladder cancers 61 thrombocytosis 61 dacarbazine DTIC 61 tyrosine kinase inhibitors TKIs 61 inherited neurodegenerative disorder 61 MKC# MT 61 TRAIL induced apoptosis 61 interferon therapy 61 Ofatumumab 61 histologic subtype 60 5q deletion 60 virological response 60 tigecycline 60 nucleoside analogues 60 chronic myeloid leukemia 60 Wilm tumor 60 inhibitor RG# 60 doripenem 60 demonstrated antitumor activity 60 metastatic pancreatic 60 hypercalcemia 60 HBeAg seroconversion 60 protease inhibitors PIs 60 sustained virologic response 60 papillary carcinoma 60 heavily pretreated patients 60 pDC 60 Upregulation 60 gastrointestinal mucositis 60 octreotide LAR 60 assessing T DM1 60 pseudotumor cerebri 60 Carcinomas 60 Friedreich ataxia 60 tyrosine kinase inhibitor 60 pegylated interferon alpha 60 GW# [003] 60 CD# mAb 60 alemtuzumab Campath